Clearmind Medicine Inc (NASDAQ: CMND)’s stock price has increased by 16.67 compared to its previous closing price of 1.17. However, the company has seen a 14.93% increase in its stock price over the last five trading sessions. InvestorPlace reported 2024-01-11 that Clearmind Medicine (NASDAQ: CMND ) stock is slipping on Thursday after the psychedelics pharmaceutical company’s shares underwent a major rally on Wednesday. The news that sent shares of CMND stock higher yesterday was a meeting with the Food and Drug Administration (FDA).
Is It Worth Investing in Clearmind Medicine Inc (NASDAQ: CMND) Right Now?
Additionally, the 36-month beta value for CMND is -1.69.
The public float for CMND is 2.92M and currently, short sellers hold a 5.48% ratio of that float. The average trading volume of CMND on May 07, 2024 was 460.50K shares.
CMND’s Market Performance
CMND stock saw an increase of 14.93% in the past week, with a monthly gain of 21.88% and a quarterly increase of -12.50%. The volatility ratio for the week is 4.67%, and the volatility levels for the last 30 days are 7.58% for Clearmind Medicine Inc (CMND). The simple moving average for the last 20 days is 12.78% for CMND stock, with a simple moving average of -70.20% for the last 200 days.
CMND Trading at 7.11% from the 50-Day Moving Average
After a stumble in the market that brought CMND to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -94.24% of loss for the given period.
Volatility was left at 7.58%, however, over the last 30 days, the volatility rate increased by 4.67%, as shares surge +6.82% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -18.50% lower at present.
During the last 5 trading sessions, CMND rose by +18.72%, which changed the moving average for the period of 200-days by -89.54% in comparison to the 20-day moving average, which settled at $1.2148. In addition, Clearmind Medicine Inc saw -51.42% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for CMND
The total capital return value is set at -0.82. Equity return is now at value -181.87, with -109.65 for asset returns.
Based on Clearmind Medicine Inc (CMND), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -38.69. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is -5.01.
Currently, EBITDA for the company is -8.42 million with net debt to EBITDA at 2.49. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.96.
Conclusion
In conclusion, Clearmind Medicine Inc (CMND) has seen mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
